The Platform brings together nearly 40 of the leading players in regenerative medicine from across 16 different universities, creating a critical mass of expertise and knowledge. Together they are tackling the major bottlenecks of regenerative medicine to unlock its vast potential and transform healthcare as we know it today.
The Platform comprises of three interdisciplinary and complementary research Hubs. Each Hub has its own broad but distinctive focus, dedicated research team and connections to commercial and clinical end-users. Collectively, they provide a central source of expertise and knowledge – generating new tools, protocols and resources that can be utilised by other research groups in both academia and industry. See an overview of our research hubs here.
Governance
Oversight of the Platform and its progress is provided through a high level independent Programme Board and Executive Group from the Sponsors. The Sponsors also provide the UKRMP Secretariat and Programme Manager. Details are as follows:
Executive Group
Dr Rob Buckle
Chief Science Officer, MRC
Professor Paul Moss
Director of Research and Knowledge Transfer, University of Birmingham, UK, Chair UKRMP Programme Board
Dr Philippa Hemmings
Head of Healthcare Technologies, EPSRC
Professor Melanie Welham
Chief Executive, BBSRC
Programme Board
Professor Paul Moss (Chair), Director of Research and Knowledge Transfer, University of Birmingham, UK
Professor Nissim Benvenisty, Director, The Azrieli Centre for Stem Cells and Genetic Research, The Hebrew University of Jerusalem, ISRAEL
Professor Kenneth Boheler, Department of Biomedical Engineering, Johns Hopkins University, USA
Dr Gillian Burgess, Executive Vice President and Head of Research, Grüenthal Group, GERMANY
Professor Jöns Hilborn, Head of Polymer Chemistry, Dept of Materials Chemistry, Uppsala University, SWEDEN
Dr Bo Kara, Evox Therapeutics
Professor Dr Petra Reinke, Head of Kidney Transplant Outpatient Clinic, Platform D Immune System and GMP-Facility, Berlin-Brandenburg Centre for Regenerative Therapies, GERMANY
Professor Anne Rosser, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK
Professor Christine Mummery, Leiden University Medical Centre, NETHERLANDS
Professor Gerry Graham, Institute of Immunology, Immunity and Inflammation, University of Glasgow, UK
UKRMP Science Manager
Natasha Jardine
Funded by
